Evaluation of bleeding risk and measurement methods in dental patients

Medicina Oral, Patologia Oral y Cirugia Bucal

Volumn 15, Issue 6, 2010, Pages

  Cañigral, Aranza ^a   Silvestre, Francisco Javier ^a,b   Cañigral, Guillermo ^c   Alós, Manuel ^c   Garcia Herraiz, Ariadna ^a   Plaza, Andres ^b  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c Castellon General Hospital   (Spain)

Author keywords

Antiplatelet drugs; Antithrombotic treatment; Bleeding risk; Oral surgery

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; EPTIFIBATIDE; LOW MOLECULAR WEIGHT HEPARIN; NONSTEROID ANTIINFLAMMATORY AGENT; TIROFIBAN;

ADOLESCENT; ADULT; AGED; ANALYTIC METHOD; ANTICOAGULANT THERAPY; ARTICLE; BLOOD CELL COUNT; BLOOD CLOTTING PARAMETERS; BLOOD EXAMINATION; CLINICAL EVALUATION; CLINICAL PRACTICE; CLINICAL TRIAL; COHORT ANALYSIS; DENTAL SURGERY; DISEASE SEVERITY; DRUG COMBINATION; ELDERLY CARE; FEMALE; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OBSERVATIONAL STUDY; ORAL BLEEDING; PROSPECTIVE STUDY; RISK; THROMBOCYTE FUNCTION; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; ORAL SURGICAL PROCEDURES; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; RISK ASSESSMENT; YOUNG ADULT;

EID: 78649686837     PISSN: 16984447     EISSN: 16986946     Source Type: Journal    
DOI: 10.4317/medoral.15.e863     Document Type: Article

References (20)

1. Van Diermen DE, Aartman IH, Baart JA, Hoogstraten J, Van der Waal I. Dental management of patients using antithrombotic drugs: critical appraisal of existing guidelines. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107:616-24.
2. Landefeld CS, Anderson PA, Goodnough LT, Moir TW, Hom DL, Rosenblatt MW, et al. The bleeding severity index: validation and comparison to other methods for classifying bleeding complications of medical therapy. J Clin Epidemiol. 1989;42:711-8.
3. Vicente Barrero M, Knezevic M, Tapia Martín M, Viejo Llorente A, Orengo Valverde JC, García Jiménez F, et al. Oral surgery in patients undergoing oral anticoagulant therapy. Med Oral. 2002;7:63-6, 67-70.
4. Morimoto Y, Niwa H, Minematsu K. Hemostatic management of tooth extractions in patients on oral antithrombotic therapy. J Oral Maxillofac Surg. 2008;66:51-7.
5. Krishnan B, Shenoy NA, Alexander M. Exodontia and antiplatelet therapy. J Oral Maxillofac Surg. 2008;66:2063-6.
6. Al-Belasy FA, Amer MZ. Hemostatic effect of n-butyl-2-cyanoacrylate (histoacryl) glue in warfarin-treated patients undergoing oral surgery. J Oral Maxillofac Surg. 2003;61:1405-9.
7. Nematullah A, Alabousi A, Blanas N, Douketis JD, Sutherland SE. Dental surgery for patients on anticoagulant therapy with warfarin: a systematic review and meta-analysis. J Can Dent Assoc. 2009;75:41.
8. Arrieta Blanco JJ, Bartolomé Villar B, Juzgado A, Mourelle Martínez R. Assessment of PFA-100 system for the measurement of bleeding time in oral surgery. Med Oral Patol Oral Cir Bucal. 2006;11:E514-9.
9. Goldenberg NA, Jacobson L, Manco-Johnson MJ. Brief communication: duration of platelet dysfunction after a 7-day course of Ibuprofen. Ann Intern Med. 2005;142:506-9.
10. Dyszkiewicz-Korpanty A, Olteanu H, Frenkel EP, Sarode R. Clopidogrel anti-platelet effect: an evaluation by optical aggregometry, impedance aggregometry, and the platelet function analyzer (PFA-100). Platelets. 2007;18:491-6.
11. Madsen EH, Schmidt EB, Maurer-Spurej E, Kristensen SR. Effects of aspirin and clopidogrel in healthy men measured by platelet aggregation and PFA-100. Platelets. 2008;19:335-41.
12. Mueller T, Dieplinger B, Poelz W, Haltmayer M. Utility of the PFA-100 instrument and the novel multiplate analyzer for the assessment of aspirin and clopidogrel effects on platelet function in patients with cardiovascular disease. Clin Appl Thromb Hemost. 2009;15:652-9.
13. Mengistu AM, Wolf MW, Boldt J, Röhm KD, Lang J, Piper SN. Evaluation of a new platelet function analyzer in cardiac surgery: a comparison of modified thromboelastography and whole-blood aggregometry. J Cardiothorac Vasc Anesth. 2008;22:40-6.
14. Siller-Matula JM, Spiel AO, Lang IM, Kreiner G, Christ G, Jilma B. Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel. Am Heart J. 2009;157:148.e1-5.
15. Sibbing D, Schulz S, Braun S, Morath T, Stegherr J, Mehilli J, et al. Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement. J Thromb Haemost. 2010;8:250-6.
16. Brennan MT, Valerin MA, Noll JL, Napeñas JJ, Kent ML, Fox PC, et al. Aspirin use and post-operative bleeding from dental extractions. J Dent Res. 2008;87:740-4.
17. Partridge CG, Campbell JH, Alvarado F. The effect of platelet-altering medications on bleeding from minor oral surgery procedures. J Oral Maxillofac Surg. 2008;66:93-7.
18. Madan GA, Madan SG, Madan G, Madan AD. Minor oral surgery without stopping daily low-dose aspirin therapy: a study of 51 patients. J Oral Maxillofac Surg. 2005;63:1262-5.
19. Grines CL, Bonow RO, Casey DE Jr, Gardner TJ, Lockhart PB, Moliterno DJ, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Dent Assoc. 2007;138:652-5.
20. Shah PR, Yepes JF, Valenza JA. Combination of aspirin and clopidogrel for the prevention of thrombosis: implications for the dental practitioner. Gen Dent. 2007;55:517-22.